around
yr
hybridoma
method
kohler
milstein
serv
gener
method
product
monoclon
antibodi
method
base
upon
immort
singl
b
lymphocyt
taken
donor
immort
fusion
myeloma
cell
line
work
laboratori
anim
bcell
donor
must
hyperimmun
antigen
interest
ensur
high
proport
splenic
lymphocyt
synthes
antibodi
intend
target
least
principl
b
cell
specif
antigen
could
select
fusion
practic
rare
done
cell
fusion
select
hybridoma
carri
drug
block
nucleotid
synthesi
salvag
surviv
line
clone
screen
synthesi
antibodi
antigen
interest
system
work
well
laborintens
difficult
control
precis
specif
antibodi
emerg
screen
fundament
limit
also
exist
method
monoclon
antibodi
product
found
upon
immun
donor
anim
problem
aris
gener
antibodi
self
antigen
eg
cell
surfac
marker
protein
conserv
sequenc
eg
protein
near
ident
mice
human
molecul
poorli
immunogen
structur
eg
carbohydr
similarli
problemat
mixtur
antigen
use
immun
host
respons
natur
bias
antigen
present
highest
concentr
immunogen
host
immun
system
method
obviou
limit
toxic
molecul
focu
interest
project
period
unpredict
requir
monoclon
antibodi
immun
fusion
screen
must
carri
time
new
reagent
requir
obviou
cost
time
implic
past
yr
technolog
develop
open
complet
differ
avenu
product
monoclon
antibodi
method
found
upon
sever
conceptu
simpl
principl
throughout
recombin
philosophi
rout
monoclon
antibodi
isol
employ
fulllength
antibodi
would
produc
mammalian
immun
system
construct
later
stage
requir
instead
work
antigenbind
fragment
typic
fab
fragment
singlechain
fv
fragment
scfv
fig
modest
size
protein
kda
fab
kda
scfv
versu
kda
fulllength
antibodi
igg
make
possibl
routin
express
bacteria
import
note
howev
fragment
retain
abil
interact
antigen
potenti
high
affin
fab
fragment
conventi
produc
proteolyt
digest
fulllength
antibodi
use
papain
cleavag
antibodi
flexibl
hing
region
releas
monoval
antigenbind
fragment
compris
immunoglobulin
light
chain
vh
domain
heavi
chain
fig
fab
thu
retain
origin
immunoglobulin
ig
capac
recogn
antigen
constitu
chain
held
togeth
natur
forc
associ
contrast
natur
equival
scfv
protein
interact
vh
vl
domain
impart
stabil
tether
flexibl
linker
enhanc
consider
translat
singl
protein
also
enabl
construct
simpl
express
system
synthesi
bacteria
construct
scfv
antibodi
often
retain
high
affin
origin
antigen
object
chapter
explain
antibodi
fragment
construct
molecular
biolog
protein
possess
abil
bind
biomolecul
interest
conveni
isol
signific
goal
accomplish
quicker
greater
control
applic
hybridoma
method
technolog
also
less
prone
constraint
indic
select
process
take
place
vitro
gener
monoclon
antigenspecif
fab
scfv
recombin
method
bear
littl
relat
convent
hybridoma
technolog
outset
larg
librari
antigenbind
fragment
must
gener
whilst
materi
librari
construct
sourc
lymphoid
tissu
anim
human
subject
entir
synthet
librari
becom
popular
mani
advantag
discuss
whatev
origin
librari
form
bacteriophag
system
viru
within
collect
possess
surfac
antibodi
fragment
potenti
bind
antigen
carri
within
capsid
code
sequenc
ig
fig
linkag
phenotyp
abil
interact
target
molecul
genotyp
code
sequenc
antigenbind
protein
crucial
follow
numer
option
exist
extract
clone
phage
librari
abil
interact
target
molecul
note
librari
gener
nonimmun
biolog
sourc
synthet
mean
term
antigen
becom
meaningless
target
describ
better
molecul
antibodi
sought
simplest
form
select
involv
coat
plastic
surfac
target
molecul
applic
viral
librari
phage
display
antibodi
fragment
affin
coat
surfac
becom
immobil
surfac
other
wash
away
recoveri
typic
low
stage
select
phage
recov
surfac
infect
bacteria
therebi
replic
much
higher
number
repeat
round
select
recoveri
amplif
targetbind
clone
recov
librari
enrich
favor
condit
select
stage
antibodi
fragment
present
surfac
viru
express
fusion
one
compon
viral
capsid
essenti
antibodi
display
phage
surfac
simpl
manipul
antibodi
fragment
also
express
independ
freeli
solubl
protein
guid
leader
peptid
fig
protein
export
releas
bacteri
periplasm
fold
assembl
case
fab
fragment
take
place
mani
vector
encod
peptid
tag
enabl
purif
eg
histidin
repeat
detect
eg
cmyc
flag
translat
product
fig
character
viral
clone
recov
phage
display
take
number
path
firstli
immunoassay
either
viru
phage
elisa
individu
protein
solubl
protein
elisa
confirm
specif
antibodi
fragment
target
natur
extens
experi
western
blot
epitop
map
determin
affin
surfac
plasmon
reson
sequenc
read
frame
antibodi
fragment
character
determin
divers
clone
recov
purif
solubl
antibodi
enabl
biolog
properti
protein
assess
eg
seek
abil
antibodi
fragment
inhibit
action
target
molecul
process
involv
adapt
antibodi
fragment
take
mani
form
natur
biolog
activ
full
length
antibodi
restor
reclon
code
sequenc
mammalian
express
vector
carri
antibodi
constant
domain
capac
fragment
bind
target
har
creat
fusion
report
eg
locat
target
molecul
cell
enzym
eg
immunoassay
target
molecul
bioactiv
agent
eg
toxin
fusion
enabl
specif
elimin
defin
popul
cell
vitro
vivo
rang
option
littl
wonder
phage
display
recombin
antibodi
technolog
rapidli
becom
popular
experiment
techniqu
construct
custom
librari
take
start
point
cdna
appropri
biolog
sourc
contain
divers
rang
ig
transcript
mani
librari
prepar
human
donor
vaccin
infect
particular
pathogen
product
exampl
zwick
colleagu
describ
isol
character
hivneutr
antibodi
deriv
hiv
seroposit
donor
equal
immun
respons
activ
patient
rang
syndrom
condit
sampl
access
lymphoid
tissu
arrang
fostieri
et
al
report
isol
myasthenia
gravi
patient
fab
antibodi
acetylcholin
receptor
note
sampl
need
protect
degrad
rna
recoveri
storag
snapfreez
storag
use
proprietari
protect
eg
rnalat
ambion
strongli
recommend
sampl
spleen
lymph
node
ideal
librari
construct
may
hard
obtain
human
sourc
may
exampl
ethic
cultur
legal
constraint
access
materi
post
mortem
analysi
tissu
taken
surgeri
inform
consent
sampl
human
blood
may
easier
sever
report
literatur
librari
construct
materi
sampl
way
embark
approach
worth
consid
number
b
lymphoblast
circul
blood
rel
low
appear
antigenspecif
b
cell
may
transitori
infect
vaccin
etc
factor
constrain
yield
cdna
divers
ig
transcript
librari
construct
possibl
isol
peripher
blood
lymphocyt
purifi
antigen
expand
vitro
small
number
even
singl
b
lymphocyt
overcom
first
issu
construct
larg
librari
contain
antibodi
mani
chemic
divers
target
sever
investig
deliber
chosen
sampl
human
repertoir
use
materi
normal
donor
b
lymphocyt
bear
igm
surfac
select
blood
lymphoid
tissu
altern
transcript
encod
igm
specif
recov
pcr
later
stage
drive
construct
librari
toward
naiv
repertoir
sampl
materi
vaccine
individu
expos
pathogen
enrich
display
librari
high
affin
antibodi
target
may
immedi
relev
eg
toxin
microbi
virul
factor
librari
may
also
repres
snapshot
divers
humor
respons
time
sampl
aid
analysi
divers
respons
genet
basi
eg
use
particular
famili
immunoglobulin
gene
featur
may
univers
benefici
librari
may
overpopul
clone
reactiv
immunodomin
product
recogn
donor
immun
system
librari
also
form
immunoglobulin
express
donor
time
sampl
antibodi
sequenc
express
well
bacteri
system
use
propag
librari
creat
gap
repertoir
librari
sort
limit
overcom
gener
librari
diversifi
synthet
method
scaffold
sequenc
chosen
known
express
success
bacteria
diversifi
produc
librari
screen
reactiv
tremend
rang
chemic
divers
target
concept
singl
pot
librari
singl
resourc
contain
antibodi
practic
target
given
sourc
cdna
lymphoid
tissu
next
object
recov
antibodycod
sequenc
use
polymeras
chain
reaction
specif
primer
allow
extract
amplif
antibodycod
sequenc
transcript
present
sampl
herein
lie
paradox
natur
antibodi
translat
sequenc
enorm
divers
repertoir
recov
manag
number
pcr
primer
fortun
sequenc
divers
concentr
region
code
complementaritydetermin
region
cdr
part
protein
contact
antigen
cdr
support
sequenc
framework
region
fr
conserv
sequenc
human
murin
immun
system
antibodi
code
sequenc
assembl
gene
segment
develop
b
lymphocyt
numer
group
smaller
number
famili
conserv
fr
sequenc
mani
speci
antibodi
repertoir
found
upon
limit
use
ig
gene
segment
famili
overal
impact
featur
huge
molecular
divers
recov
repres
fashion
signific
manag
number
amplif
reaction
major
decis
point
aris
point
librari
construct
fab
scfv
antibodi
fragment
govern
actual
primer
set
use
recoveri
repertoir
fab
fragment
gener
question
aris
prefer
antibodi
particular
class
consider
mind
human
antibodi
heavi
chain
repertoir
recov
pcr
combin
primer
anneal
code
sequenc
anneal
code
sequenc
igg
constant
domain
similar
consider
govern
number
reaction
primer
set
requir
recoveri
light
chain
repertoir
mice
men
eg
de
haard
librari
although
speci
fewer
primer
set
often
need
restrict
usag
germlin
segment
near
ident
method
use
decid
scfv
librari
construct
except
natur
primer
use
amplif
primer
specif
sequenc
light
heavi
chain
cdna
pair
primer
anneal
sequenc
eg
vaughan
librari
j
segment
rearrang
b
cell
form
part
ig
read
frame
modest
number
mani
speci
anim
singl
j
segment
util
repertoir
recov
reason
number
pcr
reaction
use
combin
heavi
chain
light
chain
primer
depend
upon
vector
use
librari
construct
restrict
site
includ
primer
use
pcr
mani
case
combin
vectorderiv
sequenc
choic
restrict
site
ensur
nearn
protein
sequenc
recombin
product
construct
larg
librari
patient
materi
investig
chosen
clone
heavi
light
chain
pcr
product
hold
vector
eg
de
haard
librari
purpos
first
materi
accumul
period
time
eg
patient
materi
logist
reason
obtain
regularli
enabl
pcr
product
archiv
stabl
form
pend
librari
construct
second
pcr
product
digest
transfer
display
vector
therebi
gener
librari
excis
insert
convincingli
demonstr
ambigu
suitabl
ligat
restrict
enzym
chosen
clone
usual
abl
digest
dna
close
termini
duplex
effici
issu
concern
recognit
site
posit
ensur
effici
digest
howev
excis
amplicon
hold
vector
provid
clear
confirm
antibodi
sequenc
readi
ligat
phage
display
vector
extens
adapt
differ
investig
match
individu
need
follow
properti
typic
irrespect
whether
scfv
fab
librari
prepar
fig
display
upon
filament
phage
piii
prefer
anchor
phagemid
vector
supersed
use
viral
genom
dna
except
specialist
purpos
eg
multival
display
larg
shift
singlestrand
dna
carri
within
viral
capsid
independ
replic
doublestrand
plasmid
bacteria
ideal
purif
high
yield
restrict
analysi
sequenc
protein
express
studi
extrem
straightforward
asid
plasmid
origin
replic
select
marker
viral
sequenc
enabl
packag
virion
vector
possess
promot
express
clone
antibodi
sequenc
typic
p
lac
eas
regul
bacteri
leader
sequenc
eg
pelb
ompa
leader
sequenc
clone
site
ig
insert
fig
fab
display
vector
usual
carri
simpl
dicistron
operon
independ
express
translat
export
heavi
light
chain
compon
eg
scfv
display
vector
linker
sequenc
tether
vh
vl
compon
includ
vector
introduc
pcr
ligat
vector
order
antibodi
fragment
display
ig
sequenc
lie
infram
giii
code
sequenc
piii
minor
phage
coat
protein
present
five
copi
tip
assembl
viru
fig
piii
protein
mediat
infect
bacteri
host
phage
interact
bacteri
f
pilu
tola
coreceptor
pioneer
work
smith
demonstr
phage
infect
could
retain
even
peptid
protein
fuse
piii
rang
featur
may
present
interven
sequenc
display
vector
becom
convent
includ
amber
stop
codon
part
vector
fig
provid
option
express
antibodypiii
fusion
protein
display
suppressor
strain
escherichia
coli
eg
move
construct
nonsuppress
bacteri
host
eg
allow
express
antibodi
fragment
solubl
protein
goal
achiev
slightli
effort
excis
giii
sequenc
use
flank
restrict
site
gener
compat
termini
relig
histidin
repeat
facilit
protein
purif
tag
immunochem
detect
also
common
featur
part
vector
fig
pcr
product
repertoir
recoveri
clone
display
vector
transform
appropri
strain
e
coli
viral
assembl
initi
two
viral
sequenc
present
vector
giii
packag
signal
ad
helper
phage
eg
vc
stratagen
full
rang
viral
protein
synthes
bacteri
host
viral
assembl
begin
singlestrand
form
phagemid
rather
helper
phage
genom
packag
progeni
phage
filament
bacteriophag
releas
e
coli
catastroph
lytic
event
cf
phage
lambda
phage
rather
extrud
viral
protein
accumul
inner
membran
assembl
form
capsid
dna
packag
virion
capsid
cap
copi
minor
coat
protein
piii
crucial
stage
regard
format
display
librari
low
level
express
antibodypiii
fusion
phagemid
achiev
growth
bacteria
low
concentr
glucos
therebi
allow
express
lac
promot
lead
accumul
recombin
protein
bacteri
membran
cap
take
place
mixtur
piii
protein
wildtyp
piii
encod
helper
phage
antibodypiii
phagemid
vector
incorpor
capsid
fig
estim
one
two
fusion
protein
commonli
incorpor
balanc
compris
wildtyp
piii
thu
progeni
phage
carri
phagemid
display
surfac
encod
antibodi
fragment
event
take
place
across
stock
bacteria
transform
recov
ig
repertoir
phage
display
librari
result
properti
helper
phage
use
procedur
extens
refin
recent
year
select
librari
target
biomolecul
aid
elimin
phage
display
wildtyp
piii
interact
select
surfac
nonspecif
fashion
helper
phage
modifi
includ
trypsinsensit
site
piii
treatment
enzym
render
noninfect
partner
display
vector
express
piii
lack
suscept
proteolysi
use
inactiv
phage
lack
antibodi
surfac
altern
approach
mutat
helper
phage
carri
truncat
version
giii
unabl
contribut
infect
process
display
librari
gener
size
potenti
util
estim
number
way
absolut
number
viru
present
determin
titrat
along
simpl
principl
infect
bacteria
phage
transduc
vector
bacteri
host
therebi
confer
upon
bacteria
resist
antibiot
sampl
librari
thu
serial
dilut
ad
aliquot
cultur
bacteria
express
f
pilu
frequenc
bacteria
convert
antibiot
resist
establish
phage
stock
transduc
unit
per
ml
routin
obtain
plasmid
dna
reisol
bacteria
infect
way
analysi
restrict
analysi
coloni
pick
random
determin
frequenc
complet
ig
insert
within
librari
ligat
amplicon
display
vector
rare
effici
use
know
proport
librari
lack
heavi
light
chain
compon
fab
vh
vl
region
scfv
divers
ig
sequenc
carri
librari
also
import
paramet
estim
digest
ig
insert
restrict
enzym
like
bstni
enzym
recogn
base
sequenc
cc
gg
happen
occur
commonli
ig
v
region
code
sequenc
given
like
occurr
sequenc
display
vector
import
antibodi
v
region
insert
specif
recov
pcr
restrict
digest
analysi
fail
restrict
profil
like
obscur
vectorderiv
fragment
detail
assess
librari
divers
made
sequenc
scfv
insert
sequenc
primer
design
upstream
downstream
flank
vector
sequenc
either
strand
linker
region
fab
insert
v
region
sequenc
rather
shorter
henc
may
possibl
sequenc
region
interest
use
primer
bacteri
leader
upstream
vh
vl
insert
although
costli
timeconsum
approach
sever
signific
advantag
restrict
analysi
extent
locat
divers
thoroughli
assess
amplicon
repertoir
recoveri
disproportion
repres
librari
identifi
degre
divers
present
librari
also
assess
perhap
import
benefit
sequenc
read
frame
librari
check
integr
cdna
prepar
lymphoid
tissu
includ
transcript
b
cell
undergo
somat
hypermut
process
capac
introduc
stop
codon
rare
shift
read
frame
similarli
use
pcr
repertoir
recoveri
introduc
error
low
frequenc
synthet
diversifi
librari
stop
codon
introduc
higher
frequenc
altern
method
employ
check
integr
read
frame
pick
clone
random
librari
appropri
manipul
see
follow
check
express
solubl
recombin
antibodi
captur
elisa
dot
blot
western
blot
one
attract
featur
phage
display
speed
select
librari
execut
flexibl
method
select
potenti
direct
extract
antibodi
direct
target
interest
worth
compar
latter
featur
convent
monoclon
method
drive
forc
toward
antibodi
interest
frequenc
b
cell
desir
specif
amongst
hybridoma
popul
simplest
form
select
take
place
upon
conveni
surfac
often
plastic
coat
target
applic
pan
method
origin
devis
smith
immunochem
procedur
surfac
need
block
minim
nonspecif
bind
librari
phage
avoid
captur
phage
bind
block
reagent
blocker
often
skim
milk
purifi
protein
like
serum
albumin
gelatin
also
use
preincub
phage
stock
reduc
substanti
chanc
interact
block
protein
present
select
surfac
number
phage
ad
surfac
usual
ensur
specif
calcul
exist
librari
repres
sever
thousandfold
allow
ampl
opportun
recoveri
incub
surfac
wash
rigor
phage
remain
attach
recov
recoveri
though
chang
ph
addit
mild
chaotrop
agent
proteas
phage
system
appropri
adapt
see
descript
whilst
elut
must
break
interact
display
antibodi
targetco
surfac
must
harsh
impair
abil
viru
infect
bacteria
fortun
infect
process
robust
recov
phage
infect
appropri
strain
bacteria
serv
two
import
purpos
firstli
allow
estim
made
number
viru
recov
select
done
measur
frequenc
bacteria
transduc
antibiot
resist
secondli
number
phage
recov
first
round
select
modest
number
rang
typic
repres
low
percentag
input
infect
bacteria
recoveri
antibioticresist
coloni
reinfect
helper
phage
allow
amplif
recov
sampl
number
appropri
second
round
select
round
often
take
place
surfac
coat
success
lower
concentr
target
molecul
effort
refin
select
toward
antibodi
highest
affin
interact
percentag
phage
recov
round
select
often
climb
sharpli
round
one
two
elev
may
occur
round
suggest
success
sequenc
clone
pick
random
select
experi
often
reveal
emerg
common
sequenc
cdr
collect
initi
appear
divers
indic
progress
enrich
take
place
phage
select
import
note
howev
select
blind
despit
care
experiment
design
drift
intend
direct
number
reason
exampl
phage
low
propens
interact
select
surfac
abl
replic
quickli
rapidli
domin
output
similarli
antibodi
react
contamin
high
affin
rather
intend
target
emerg
select
suffer
problem
show
sign
success
select
proce
failur
becom
appar
test
immunoassay
later
stage
problem
aris
speed
phage
display
mean
setback
quickli
rectifi
format
select
limit
ingenu
investig
avoid
conform
chang
target
bind
plastic
surfac
solutionbas
select
method
popular
often
target
modifi
addit
small
ligand
eg
biotin
phage
mix
solut
target
captur
plastic
surfac
coat
streptavidin
collect
use
magnet
bead
select
solut
also
follow
captur
surfac
coat
anoth
antibodi
direct
target
select
method
also
use
small
target
molecul
may
bind
effici
plastic
direct
bind
select
surfac
may
obscur
featur
potenti
import
antibodi
small
target
molecul
also
isol
phage
display
use
carrier
protein
target
coupl
larger
protein
carrier
either
chemic
activ
genet
fusion
conjug
coat
select
surfac
natur
antibodi
may
bound
select
via
interact
carrier
drive
select
toward
molecul
interest
select
next
round
take
place
use
conjug
employ
differ
carrier
protein
lead
import
principl
employ
phage
display
concept
neg
select
although
select
strategi
natur
spring
mind
clone
bind
coat
surfac
retain
carri
forward
success
round
equal
possibl
deplet
coat
surfac
leav
behind
antibodi
captur
valuabl
seek
antibodi
featur
target
one
distinguish
close
relat
biomolecul
appli
librari
irrelev
similar
target
librari
deplet
antibodi
direct
toward
common
share
motif
neg
select
step
phage
left
free
solut
taken
forward
posit
select
target
altern
round
neg
posit
select
may
drive
process
toward
specif
interest
exampl
serv
illustr
aspect
select
recent
review
consult
appreci
enorm
varieti
select
strategi
employ
investig
one
common
featur
select
allud
earlier
roundonround
divers
recov
clone
fall
enrich
take
place
use
complex
target
compris
multipl
molecular
speci
antibodi
potenti
valu
discard
earli
round
select
overcom
wastag
robot
method
emerg
particular
valu
deriv
antibodi
use
proteom
thousand
clone
pick
evalu
earli
stage
select
check
grid
onto
membran
coat
target
interest
assess
phage
number
conveni
determin
titrat
experi
import
calcul
size
librari
recoveri
viru
select
amplif
prepar
later
round
pan
procedur
exploit
abil
phage
infect
strain
e
coli
transduc
express
antibiot
marker
carri
phagemid
henc
serial
dilut
phage
stock
infect
e
coli
provid
conveni
assay
select
success
extract
clone
librari
customari
observ
low
percentag
recoveri
first
round
select
rise
sever
order
magnitud
next
round
elev
may
seen
later
round
select
necessarili
impli
clone
intend
target
emerg
strong
indic
select
basi
specif
clone
recov
select
conveni
determin
elisa
use
variou
format
one
assay
immedi
benefit
take
mix
output
phage
round
select
test
reactiv
target
rang
irrelev
protein
biomolecul
bind
viru
immunoassay
surfac
detect
reagent
capsid
depend
upon
supplier
reagent
may
directli
conjug
enzym
report
eg
horseradish
peroxidas
addit
secondari
conjug
may
requir
viral
input
assay
mix
composit
assay
often
term
polyclon
phage
elisa
use
appli
initi
assess
success
select
protocol
along
rise
percentag
recoveri
viru
increas
elisa
strength
polyclon
phage
elisa
versu
intend
target
provid
sign
specif
select
assum
signal
irrelev
target
remain
consist
low
assay
exampl
confirm
virus
emerg
inadvert
select
block
materi
use
pan
natur
progress
evalu
output
select
identifi
individu
clone
react
intend
target
plate
use
titrat
output
round
select
use
isol
individu
clone
cultur
superinfect
helper
phage
prepar
monoclon
phage
stock
test
elisa
describ
caution
exercis
outcom
monoclon
phage
elisa
assay
typic
execut
mani
clone
simultan
common
practic
pick
exampl
clone
output
round
select
use
microtitr
plate
bacteri
cultur
superinfect
rare
possibl
titrat
number
viru
use
monoclon
phage
elisa
henc
fluctuat
elisa
data
among
clone
test
may
reflect
extent
variat
viral
input
rather
strength
interact
target
anoth
caveat
phagebas
elisa
gener
signal
appar
strength
affin
display
antibodi
target
moder
low
signal
may
heavili
depend
upon
multival
display
ie
benefit
avid
effect
rather
affin
instanc
express
antibodi
monoval
solubl
protein
fail
gener
signal
strength
elisa
might
expect
initi
test
phage
final
aspect
technolog
need
consid
influenc
bacteri
host
propag
viru
often
carri
suppressor
strain
e
coli
eg
ensur
translat
amber
stop
codon
depend
upon
vector
may
posit
antibodi
piii
read
frame
essenti
synthesi
fusion
protein
requir
display
host
background
amber
stop
codon
elsewher
read
frame
eg
locat
cdr
diversif
may
gener
synthet
also
translat
phage
carri
sequenc
may
abl
bind
target
biomolecul
elisa
construct
transfer
nonsuppress
bacteri
host
eg
fulllength
antibodi
form
clone
appear
promis
monoclon
phage
elisa
unreact
later
stage
character
reason
vital
signific
number
clone
chosen
monoclon
phage
elisa
character
choic
entir
favor
clone
gener
strongest
signal
phage
elisa
issu
concern
viral
input
elisa
also
worth
consid
natur
target
point
evalu
process
outcom
assay
use
judg
phage
recov
screen
intend
specif
therefor
vital
target
use
elisa
pure
possibl
control
includ
assay
determin
phage
isol
reactiv
potenti
minor
contamin
block
agent
use
select
anoth
compon
select
system
eg
nake
plastic
biotin
streptavidin
etc
assumpt
clone
recov
select
intend
specif
may
also
possibl
assess
stage
recognit
take
place
particular
featur
target
biomolecul
exampl
competit
elisa
anoth
monoclon
antibodi
ligand
biomolecul
reactiv
target
peptid
deriv
target
sequenc
use
good
effect
final
coat
immunoassay
surfac
differ
form
target
eg
nativ
protein
recombin
form
use
select
close
homologu
target
perhap
taken
speci
protein
modifi
posttransl
stage
phosphoryl
glycosyl
addit
fatti
acyl
moieti
chemic
deriv
small
target
speci
eg
form
target
lack
particular
molecular
featur
altern
peptid
sequenc
help
defin
antibodi
show
particular
promis
earli
stage
character
clone
emerg
phase
analysi
sequenc
assess
divers
cdr
librari
deriv
immun
sourc
rang
ig
segment
contribut
respons
target
vivo
consensu
sequenc
may
appear
cdr
antibodi
isol
stringent
select
method
step
also
worthwhil
identifi
whether
ident
clone
present
dna
phagemid
display
vector
easili
isol
sequenc
approach
signific
benefit
assess
divers
recov
clone
restrict
analysi
bstni
frequent
cut
endonucleas
describ
primer
sequenc
may
design
flank
region
antibodi
read
frame
code
sequenc
scfv
linker
display
vector
design
minim
degre
manipul
move
express
antibodypiii
fusion
synthesi
solubl
monoval
protein
eg
fab
display
vector
deriv
piii
code
sequenc
excis
digest
spei
nhei
enzym
gener
compat
termini
vector
fragment
isol
relig
express
fab
e
coli
host
mani
scfv
display
vector
possess
amber
stop
codon
read
frame
antibodi
phage
coat
protein
fig
infect
viru
nonsuppress
host
eg
e
coli
therefor
lead
express
solubl
antibodi
fragment
major
display
vector
transcript
recombin
antibodi
take
place
lac
promot
customari
grow
bacteria
glucos
repress
adequ
biomass
reach
remov
glucos
centrifug
resuspens
fresh
glucosefre
medium
contain
iptg
induc
trigger
transcript
translat
choic
growth
temperatur
express
phase
import
avoid
aggreg
protein
minim
toxic
bacteri
host
though
studi
suggest
effect
yield
minim
express
often
chosen
start
point
frequent
overexpress
antibodi
lead
leakag
periplasm
content
cultur
medium
protein
purifi
purif
aid
significantli
presenc
histidin
repeat
sequenc
carboxyterminu
protein
featur
conveni
incorpor
origin
vector
materi
gener
way
use
immunoassay
blot
detect
made
igbind
protein
protein
g
l
reagent
purif
andor
peptid
tag
eg
cmyc
flag
etc
analysi
solubl
protein
differ
mani
way
origin
phage
clone
prudent
carri
forward
mani
differ
construct
appear
bind
target
movement
suppressor
mutant
express
scfvpiii
fusion
propag
phage
nonsuppressor
host
express
solubl
protein
mean
clone
posit
phage
elisa
react
poorli
solubl
antibodi
express
see
amber
stop
codon
present
ig
read
frame
truncat
antibodi
prematur
situat
ig
sequenc
express
success
bacteria
other
whilst
investig
identifi
caus
effect
mani
case
remain
unexplain
clone
custom
immun
librari
may
therefor
prove
difficult
overexpress
happen
carri
problemat
framework
sequenc
reason
success
synthet
diversifi
librari
found
upon
singl
framework
framework
chosen
one
express
consist
well
bacteri
host
affin
antibodytarget
interact
also
relev
consider
multipl
display
antibodi
phage
surfac
drive
promis
interact
phage
elisa
express
monoval
solubl
protein
construct
low
modest
affin
target
give
elisa
signal
close
background
potenti
problem
foreseen
care
experiment
design
exampl
western
dot
blot
captur
elisa
use
check
evid
express
protein
targetspecif
elisa
undertaken
data
also
use
normal
extract
quantiti
purifi
protein
taken
forward
elisa
reaction
target
rank
knowledg
roughli
equival
amount
recombin
antibodi
use
assay
issu
address
express
antibodi
scale
product
purifi
nickel
chelat
chromatographi
histidin
tag
present
affin
chromatographi
protein
g
l
accord
antibodi
sequenc
carri
determin
affin
purifi
protein
target
commonli
assess
surfac
plasmon
reson
use
instrument
biacor
recombin
antibodi
emerg
select
character
avail
code
sequenc
abil
express
protein
bacteria
open
numer
option
affin
antibodi
target
enhanc
ration
random
mutagenesi
manipul
may
refin
specif
antibodi
target
fusion
gener
link
ig
read
frame
enzym
like
alkalin
phosphatas
fluorogen
like
green
fluoresc
protein
manipul
eg
addit
termin
cystein
residu
aid
coval
attach
moieti
coupl
recombin
antibodi
protein
domain
modest
size
eg
human
kappa
constant
domain
entiti
eg
maltos
bind
protein
may
improv
yield
enabl
conveni
detect
antibodi
bind
reconstruct
fulllength
antibodi
scfv
fab
protein
may
confer
biolog
activ
abil
activ
complement
upon
target
recognit
protein
size
often
requir
express
eukaryot
system
avail
special
vector
assist
achiev
goal
antibodi
librari
mine
reactiv
wide
rang
target
use
recombin
antibodi
reagent
target
detect
character
wellillustr
area
proteom
ohara
colleagu
compar
properti
recombin
fab
librari
synthet
diversifi
human
antibodi
polyclon
antisera
target
report
fab
wellsuit
western
blot
immunohistochemistri
earlier
de
wildt
et
al
describ
experi
one
two
round
convent
screen
use
isol
phage
synthet
diversifi
librari
construct
singl
vh
vl
framework
clone
pick
grid
use
robot
onto
membran
coat
target
test
specif
studi
demonstr
capac
larg
display
librari
yield
antibodi
wide
rang
target
abil
extract
antibodi
minor
compon
complex
mixtur
given
appropri
robot
method
identif
recognit
target
investig
describ
phage
select
use
blot
prepar
gel
use
proteom
target
extract
specif
antibodi
librari
synthet
diversifi
librari
divers
resourc
extract
antibodi
human
protein
target
eg
tumor
necrosi
factor
human
chorion
gonadotropin
molecul
highli
conserv
amongst
eukaryot
therefor
poorli
immunogen
eg
ubiquitin
toxic
compound
eg
doxorubicin
possibl
antibodi
isol
phage
display
develop
diagnost
reagent
intrigu
prospect
use
construct
microarray
upon
bind
multipl
analyt
could
detect
phage
display
particularli
valuabl
area
applic
singl
highli
diversifi
resourc
librari
conveni
mine
antibodi
mani
differ
target
author
describ
use
stringent
select
method
isol
antibodi
high
affin
via
phage
display
reagent
abil
detect
low
concentr
analyt
exampl
wang
colleagu
report
format
bival
scfv
fusion
alkalin
phosphatas
immunoassay
could
detect
sever
hundr
bacillu
anthraci
cell
hour
show
replac
enzym
report
dye
increas
sensit
assay
increas
time
taken
conduct
assay
target
molecul
link
diseas
state
numer
report
isol
phage
display
antibodi
therapeut
potenti
infecti
diseas
prove
product
area
investig
one
exampl
antibodi
anthrax
toxin
shown
neutral
lethal
properti
bacteri
virul
factor
pathogenesi
establish
eg
rotaviru
emerg
viral
agent
eg
sar
also
block
recombin
antibodi
antibodi
gener
way
potenti
treatment
acut
infect
block
diseas
process
key
point
eg
interact
receptor
pathogen
product
provid
therapeut
option
use
antibiot
antivir
compound
undesir
imposs
also
offer
prophylaxi
vaccin
unavail
patient
unabl
mount
protect
respons
consequ
vaccin
area
applic
deal
infecti
agent
antibodi
phage
display
also
wide
appli
search
antibodi
antitumor
activ
care
design
select
strategi
enabl
exampl
investig
isol
antibodi
specif
marker
express
transform
cell
absent
nontransform
primari
cell
therapeut
applic
need
trigger
complement
recruit
effector
cell
exploit
case
intern
recombin
antibodi
directli
antiprolif
effect
practic
convent
applic
antibodi
phage
display
use
recombin
protein
free
solubl
reagent
howev
import
except
intrabodi
deliber
retain
cytosol
import
grow
area
applic
provid
natur
complement
mutat
gene
knockout
rnai
analysi
gene
function
creat
intrabodi
code
sequenc
antibodi
chosen
specif
reclon
mammalian
express
vector
crucial
insert
lack
leader
sequenc
construct
transfect
cell
manipul
translat
product
confin
cytosol
transfect
cell
antibodi
success
fold
bind
molecul
present
locat
potenti
block
normal
function
tag
antibodi
target
motif
direct
reloc
antibodi
nucleu
mitochondria
etc
intrabodi
find
immedi
applic
analysi
viral
gene
function
interact
viral
protein
host
factor
disrupt
bind
recombin
antibodi
cytosol
pathogen
process
inherit
condit
like
huntingdon
diseas
alzheim
cancer
similarli
analys
applic
intrabodi
techniqu
approach
enabl
definit
pathway
link
pathogenesi
contribut
defin
protein
normal
cellular
process
given
complic
deliv
antibodi
intracellular
environ
perhap
serv
rout
target
discoveri
valid
direct
rout
therapi
lastli
specif
antibodi
exploit
specif
deliveri
drug
therapeut
obvious
use
phage
display
speed
isol
antibodi
desir
target
properti
genet
fusion
use
link
recombin
antibodi
protein
possess
toxic
activ
introduct
nonn
residu
terminu
recombin
antibodi
also
allow
applic
conjug
chemistri
link
enzym
antibodi
nontox
prodrug
convert
activ
form
situ
anticanc
therapi
thrombolyt
agent
deliv
recombin
antibodi
also
use
deliveri
drug
across
blood
brain
barrier
flexibl
antibodi
phage
display
applic
limit
imagin
investig
aid
appreci
advantag
phage
display
method
hybridoma
technolog
literatur
expand
enorm
consequ
chapter
provid
overview
antibodi
isol
use
method
brief
insight
potenti
applic
inevit
use
method
exploit
continu
driven
opportun
omic
biolog
need
new
therapi
